Danish Pharmaceuticals & Biotech Potentially Undervalued Companies

Bavarian Nordic

Market Cap: DKK 13.3b

Develops, manufactures, and supplies life-saving vaccines.

H. Lundbeck

Market Cap: DKK 40.5b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products.

H. Lundbeck

Market Cap: DKK 40.5b

Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.

Genmab

Market Cap: DKK 115.3b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Gubra

Market Cap: DKK 5.8b

A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.

ALK-Abelló

Market Cap: DKK 50.3b

An allergy solutions company, develops treatments for respiratory allergy, anaphylaxis, and food allergy and new disease areas in the European Union, the United Kingdom, Norway, Switzerland, the United States, Canada, Japan, China, and internationally.